Conclusion. Ceftobiprole is a novel, broad-spectrum, parenteral cephalosporin undergoing Phase III clinical trials. Its broad spectrum of activity makes it a candidate for monotherapy of cSSSIs ...

and specific broad-spectrum antibiotics known to contribute most to antibiotic resistance (co-amoxiclav, quinolones, and cephalosporins). Secondly, a fixed amount of tax per unit of the drug.

Credit: Getty Images. Ceftobiprole is a broad spectrum cephalosporin antibiotic. The Food and Drug Administration (FDA) has accepted the New Drug Application for ceftobiprole, an investigational ...

Clinical outcomes among adult inpatients were no worse when broad-spectrum antibiotic therapy was delayed vs started early, challenging the belief that overly broad-spectrum empiric antibiotic ...

Our editors also may be in touch with follow-up questions. While there are three main types of CBD, broad-spectrum CBD specifically contains a profile of active cannabinoids from hemp (including ...

One of the most pressing health challenges in today’s swine industry is respiratory disease, as outbreaks are increasing in frequency and severity. Of course, vaccination is the primary method to ...

Patients were excluded if they had a history of an allergic reaction with or an intolerability to either cephalosporins or vancomycin, severe renal dysfunction (CL cr of <30 mL/min), hepatic ...